Cencora Overview

Company: Cencora
CEO: Robert Mauch
Symbol: COR
Exchange: NYSE
Industry: Medical - Distribution
Sector: Healthcare
About

Cencora sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers,luding hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora in August 2023. Cencora was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Continue reading...

Cencora (COR)

  • Stock Price
  • Volume
372.14 +268.97 +260.71%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Net Income

Employees

Revenue by Segment

Revenue by Region

Executive Salary

Revenue per Employee

Profit per Employee

Income Statement

Operating Income

Research & Development

Tax Rate (%)

Assets & Liabilities | Cash Flow

Total Assets

Total Liabilities

Capital Expenditure

Ratios

Return on Equity (ROE)

Return on Assets (ROA)

Debt to Equity

Profitability

Gross Profit Margin (%)

Operating Income Margin (%)

Net Income Margin (%)

Earning Per Share

EBITDA

Free Cash Flow (FCF)

Valuation

Enterprise value

Enterprise value to Revenue

Enterprise value to EBITDA

Competitors’ Revenue

Frequently Asked Questions

Who is the CEO of Cencora?

Robert Mauch is the CEO of Cencora.

What industry and sector is Cencora in?

Cencora operates in the Medical - Distribution industry and the Healthcare sector.

What are Cencora's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0001140859
  • SIC (Standard Industrial Classification):
  • ISIN (International Securities Identification Number): US03073E1055

Sign up for free to view

How many employees does Cencora have?

Cencora has 51,000 employees.

What is the revenue of Cencora?

In fiscal year 2025, Cencora generated a revenue of $321.33 Billion.

What is the net income of Cencora?

In fiscal year 2025, Cencora reported a net income of $1.55 Billion.

What is Cencora's biggest product segment?

Pharmaceutical Distribution is Cencora's biggest product segment, representing 100% of its total revenue.

When was Cencora listed on the stock exchange?

Cencora went public on Apr 4, 1995, through its Initial Public Offering (IPO), and it has been 30 years since then.

Sign up for free to view

What is the ticker symbol of Cencora, and where is it listed?

Cencora's ticker symbol is COR, and the company is listed on the NYSE stock market exchange.

What is Cencora's current stock price?

Cencora's current stock price is $372.26 as of Feb 28, 2026.

What is Cencora's market capitalization?

As of , Cencora's market cap is .

What is Cencora's ranking in the world?

Ranked #28among 2,854 companies based on market cap.

Who are the top competitors of Cencora?

Competitors of Cencora include McKesson Corporation and Cardinal Health, and more.